On the other hand, the increase of ACE2 in type I and type II pneumocytes (Roca-Ho et al., 2017) can be related with parallel changes in severity of COVID-19 in diabetic comparing to normoglycemic population, which is also reflected in higher mortality in diabetic subjects (Jeong et al., 2020). This evidence concerns the gene ACE2 and COVID-19.